Bloomios

BLMS

Medical - Pharmaceuticals · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$19,341

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+102.8% over 3y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 6.5M (2019) → 13.2M (2022)

Bloomios is a small U.S. company that makes and sells hemp-derived CBD products. Its lineup includes things like gummies, tinctures, and topical creams sold to everyday consumers and wholesale buyers such as retailers and white-label partners who put their own brand on the products. The company operates in the specialty consumer health space, where CBD products compete for shelf space alongside vitamins and supplements.

Bloomios earns money by selling its products directly to consumers online and through wholesale agreements with other businesses. It operates entirely within the United States and is a very small company with a market cap close to zero. The business currently loses money on operations, which is a serious concern given its thin financial cushion. The biggest risk it faces is staying solvent long enough to scale revenue, as negative operating margins and a tiny balance sheet leave little room for error.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-43.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-537.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

34.5%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$0 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Bloomios has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

46.3%

Healthy — 46.3% gross margin

Operating Margin

-93.8%

Losing money on operations — -93.8%

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+46.5%

Fast-growing sales (46.5% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-86.8%

Burning cash (-86.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial